Clinitech Laboratory Limited

CTLLAB

Small Cap | Healthcare
41
+6.5 (+18.84%)

Stock price as on 06 Feb 2026 at 12:18 PM

Clinitech laboratory limited share price update

As of the latest trading session, Clinitech Laboratory Limited share price is currently at ₹41, which is up by ₹6.5 from its previous closing. Today t...

Clinitech Laboratory Limited stock performance

Today’s low

₹32

Today’s high

₹41.39

₹41

52 week low

₹28.55

52 week high

₹98.99

₹41
Open
₹32.00
Previous close
₹34.50
Share volume
4,800
Total traded value (Lakh)
₹1.78
Upper circuit
₹41.40
Lower circuit
₹27.60

Clinitech Laboratory Limited fundamentals

Market cap (Cr)
₹9.40
P/E ratio (TTM)
19.94
Book value per share
₹38.68
Beta
-0.12
Return on equity
5.49%
Earnings per share (TTM)
₹1.52
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Clinitech Laboratory Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹8.23

Operating expense

₹7.90

Net income

₹0.39

Net profit margin

4.73%

Earning per share

₹1.90

EBITDA

₹1.06

Effective tax rate

29.09%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹6.40

Operating expense

₹5.93

Net income

₹0.37

Net profit margin

5.78%

Earning per share

₹2.37

EBITDA

₹1.04

Effective tax rate

25.49%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹6.35

Operating expense

₹5.50

Net income

₹0.61

Net profit margin

9.6%

Earning per share

₹4.09

EBITDA

₹1.36

Effective tax rate

29.06%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹6.38

Operating expense

₹5.76

Net income

₹0.51

Net profit margin

7.99%

Earning per share

₹3.42

EBITDA

₹1.14

Effective tax rate

27.14%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹4.55

Operating expense

₹4.06

Net income

₹0.40

Net profit margin

8.79%

Earning per share

₹6.04

EBITDA

₹0.88

Effective tax rate

25.45%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹38.69

Return on Equity (ROE)

5.49%

Return on Capital Employed (ROCE)

7.92%

Total debt to equity ratio

0.07

EBITDA margin

12.03%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹21.12

Return on Equity (ROE)

12.48%

Return on Capital Employed (ROCE)

12.25%

Total debt to equity ratio

0.32

EBITDA margin

16.09%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹15.87

Return on Equity (ROE)

28.84%

Return on Capital Employed (ROCE)

23.6%

Total debt to equity ratio

0.45

EBITDA margin

21.73%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹12.32

Return on Equity (ROE)

31.48%

Return on Capital Employed (ROCE)

31.15%

Total debt to equity ratio

0.44

EBITDA margin

17.87%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹20.86

Return on Equity (ROE)

28.78%

Return on Capital Employed (ROCE)

30.69%

Total debt to equity ratio

0.38

EBITDA margin

19.12%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹3.07

Total assets

₹10.71

Total liabilities

₹10.71

Total equity

₹8.83

Shares outstanding

₹0.22

Price to book ratio

₹1.04

Return on assets (%)

3.68%

Return on capital

4.47%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.70

Total assets

₹5.60

Total liabilities

₹5.60

Total equity

₹3.54

Shares outstanding

₹0.16

Price to book ratio

-

Return on assets (%)

6.61%

Return on capital

8.41%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.78

Total assets

₹6.03

Total liabilities

₹6.03

Total equity

₹2.38

Shares outstanding

₹0.15

Price to book ratio

-

Return on assets (%)

10.16%

Return on capital

17.98%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.10

Total assets

₹3.68

Total liabilities

₹3.68

Total equity

₹1.84

Shares outstanding

₹0.15

Price to book ratio

-

Return on assets (%)

13.9%

Return on capital

18.75%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.32

Total assets

₹2.73

Total liabilities

₹2.73

Total equity

₹1.39

Shares outstanding

₹0.06

Price to book ratio

-

Return on assets (%)

14.72%

Return on capital

20.88%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹0.55

Cash from operations

-₹0.71

Cash from investing

-₹0.72

Cash from financing

₹3.98

Net change in cash

₹2.37

Free cash flow

₹0.44

Particulars

Mar 24 (₹ value in crores)

Net income

₹0.50

Cash from operations

-₹1.13

Cash from investing

₹0.75

Cash from financing

₹0.44

Net change in cash

-₹0.08

Free cash flow

₹0.06

Particulars

Mar 23 (₹ value in crores)

Net income

₹0.86

Cash from operations

₹1.54

Cash from investing

-₹0.65

Cash from financing

₹0.08

Net change in cash

₹0.67

Free cash flow

₹1.82

Particulars

Mar 22 (₹ value in crores)

Net income

₹0.70

Cash from operations

₹1.16

Cash from investing

-₹1.46

Cash from financing

₹0.29

Net change in cash

-₹0.21

Free cash flow

₹2.67

Particulars

Mar 21 (₹ value in crores)

Net income

₹0.54

Cash from operations

₹0.53

Cash from investing

₹0.54

Cash from financing

-₹0.87

Net change in cash

₹0.04

Free cash flow

₹0.71

Clinitech Laboratory Limited technical summary

₹41
+ 18.84 ▲
10
Bearish
6
Bullish
5 Day35.6
10 Day37.2
12 Day37.7
20 Day39
26 Day39.7
50 Day41.4
100 Day45.9
200 Day58.7
5 Day35.1
10 Day38.3
12 Day38.4
20 Day39.7
26 Day40.3
50 Day43.4
100 Day41.6
200 Day57.9

33.23

PIVOT

First support
₹31.97
First resistance
₹35.77
Second support
₹29.43
Second resistance
₹37.03
Third support
₹28.17
Third resistance
₹39.57
RSI
39.46
ADX
15.54
MACD
-2.01
Williams % R
-60.2
Commodity Channel Index (CCI)
-149.06
Date
05 Feb 2026
Same day
3,600
Week
12,600
Month
8,200
1 year
-0.12
3 years
0.31
Over 1 month
-20.68%
Over 1 year
-59.4%
Over 3 months
-21.59%
Over 3 years
0%
Over 6 months
0.96%
Over 6 years
0%

Investment Returns

Over 1 Month20.68%
Over 3 Months21.59%
Over 6 Months0.96%
Over 1 Year59.4%

Clinitech Laboratory Limited Shareholding pattern


Public
37.26%
Promoter holdings
62.41%
FII
0.31%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Jagdish Umakant Nayak

6,93,700 (30.39%)

Shareholding of Promoter and Promoter Group

Jyoti Jagdish Nayak

6,75,000 (29.57%)

Shareholding of Promoter and Promoter Group

Santosh Gopalkrishna Kudva

1,33,200 (5.84%)

Public Shareholding

Krisha V Talreja

70,800 (3.1%)

Public Shareholding

Siddhesh Anant Nayak

55,500 (2.43%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Jagdish Umakant Nayak6,93,700 (30.39%)Shareholding of Promoter and Promoter Group
Jyoti Jagdish Nayak6,75,000 (29.57%)Shareholding of Promoter and Promoter Group
Santosh Gopalkrishna Kudva1,33,200 (5.84%)Public Shareholding
Krisha V Talreja70,800 (3.1%)Public Shareholding
Siddhesh Anant Nayak55,500 (2.43%)Shareholding of Promoter and Promoter Group
Ajit Sakharam Kandar51,200 (2.24%)Public Shareholding
Mukesh Thumar26,600 (1.17%)Public Shareholding
Rahul R Mahajan25,200 (1.1%)Public Shareholding
Ananya Jagdish Nayak100 (0%)Shareholding of Promoter and Promoter Group
Eshwari Anant Nayak100 (0%)Shareholding of Promoter and Promoter Group
Ashutosh Jagdish Nayak100 (0%)Shareholding of Promoter and Promoter Group
Anant Umakant Nayak100 (0%)Shareholding of Promoter and Promoter Group

About Clinitech Laboratory Limited

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai. The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai. Clinitech Laboratory are a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane, Raigad and Nav

Parent Organisation

Indian Private

NSE Symbol

Clinitech Laboratory Limited

Founded

2010

Clinitech Laboratory Limited CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)